Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8Z0Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,933
Award facts
- Contract value 100% obligated
- $70,932.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units, with a contract ceiling value of $70,932.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for military and veteran healthcare systems. This particular award for an anti-nausea medication reflects the company's ongoing role in supplying essential prescription medications and medical commodities to support the Defense Health Agency and other government healthcare systems through a flexible and comprehensive contract structure.
Quick answers
Who was awarded contract SPE2DR26F8Z0Y?
SPE2DR26F8Z0Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F8Z0Y worth?
The government has obligated $70,933 on SPE2DR26F8Z0Y.
Is contract SPE2DR26F8Z0Y an order under another contract?
Yes. SPE2DR26F8Z0Y is a delivery order under SPE2DR25D1107, an indefinite delivery contract.
Was contract SPE2DR26F8Z0Y competed?
The extent of competition for SPE2DR26F8Z0Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award